Churchill, FDR and Stalin could cooperate against Hitler, so perhaps we shouldn’t be too surprised that even amidst talk of a new Cold War, sanctions and more than a little sanctimony, people in the West are willing to make deals with Moscow in the name of fighting the new global threat, Covid-19.
Russia’s Sputnik V vaccine may have been rushed through its certification at home and been the subject of some overblown nationalist hype (not that the Oxford-AstraZeneca vaccine has been entirely free of the latter), but so far it appears to be a serious and effective jab, with a potential 91.4 per cent efficacy. Although based on a different source of modified adenovirus, a common cold virus, it is similar in many ways to the Oxford-AstraZeneca vaccine, not least in that it is relatively cheap and can be stored in a regular fridge.
There is still widespread suspicion about the vaccine in Russia, where over a million have received the first of their two jabs, but several other countries have leapt at the chance to use or license Sputnik V, including Algeria, Brazil, China, and India.
Not in the West, though.
Comments
Join the debate for just $5 for 3 months
Be part of the conversation with other Spectator readers by getting your first three months for $5.
UNLOCK ACCESS Just $5 for 3 monthsAlready a subscriber? Log in